ʻO Sacubitril Hemicalcium

ʻO ka wehewehe pōkole:

Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP
ʻO Sacubitril Hemicalcium   I-Hale      


Huahana Huahana

Huahana Huahana

NUI HUA

沙库比曲半钙盐 ʻO Sacubitril Hemicalcium 1369773-39-6 I-Hale
沙库比曲钠盐 149690-05-1 I-Hale
LCZ-4 1426129-50-1 I-Hale
LCZ-7 1012341-48-8 I-Hale
LCZ-8 1012341-50-2 I-Hale
LCZ-9 149690-12-0 I-Hale

 

Kāpae

ʻO ka paʻakai hemicalcium AHU-377 he ʻano paʻakai hemicalcium o AHU-377. He mea pale ia o neprilysin me ka waiwai IC50 o 5 nM [1].

AHU-377 a me ka angiotensin II AT1 receptor antagonist valsartan haku LCZ696 i ka 1:1 molar ratio. ʻO LCZ696 kahi mea hoʻopale neprilysin receptor angiotensin. Hiki iā ia ke hōʻemi i ke kahe koko a he lāʻau hou paha ia no ka mālama ʻana i ka hemahema o ka naʻau. ʻO AHU-377 kahi lāʻau lapaʻau, hiki ke hoʻololi ʻia e ka enzymatic cleavage o ka ethyl ester i loko o ke ʻano hana LBQ657. Ua hōʻike ʻia ʻo AHU-377(30 a me 100 mg/kg, PO) hiki ke hana i ka hopena antihypertensive ma ke ʻano i hilinaʻi ʻia i nā ʻiole DAHI-SS. Akā i ka DOCA-salt hypertensive rats, hōʻike ia i kahi emi nāwaliwali [2, 3].

Kuhikuhi:
[1] Ksander GM, Ghai RD, deJesus R, Diefenbacher CG, Yuan A, Berry C, Sakane Y, Trapani A. Dicarboxylic acid dipeptide neutral endopeptidase inhibitors. J Med Chem. 1995 Mei 12; 38(10):1689-700.
[2] Voors AA, Dorhout B, van der Meer P. ʻO ke kuleana kūpono o valsartan + AHU377 (LCZ696) i ka mālama ʻana i ka naʻau. Opin Investig Drugs. 2013 ʻAukake;22(8):1041-7.
[3] Laxminarayan G Hegde, Cecile Yu, Cheruvu Madhavi et al. Hoʻohālikelike ka maikaʻi o AHU-377, he mea hoʻopaneʻe neprilysin ikaika, i loko o ʻelua mau ʻiole o ke kiʻekiʻe kiʻekiʻe. BMC Pharmacology 2011, 11(Suppl 1):P33.

ʻO ke kinona

ʻO Sacubitril Hemicalcium

HOOLAHA ANOAI

Hoʻoponopono maikaʻi1

Manaʻo18Nā papahana Loiloi Kūlike Kūlike i ʻae ʻia4, a6apono ʻia nā papahana.

Hoʻoponopono maikaʻi2

Ua hoʻokumu ka ʻōnaehana hoʻokele maikaʻi honua kiʻekiʻe i ke kumu kūʻai.

Hoʻoponopono maikaʻi3

Holo ka nānā ʻana i ka maikaʻi ma ke ola holoʻokoʻa o ka huahana e hōʻoia i ka maikaʻi a me ka hopena therapeutic.

Hoʻoponopono maikaʻi4

Kākoʻo ka hui ʻoihana Regulatory Affairs i nā koi maikaʻi i ka wā o ke noi a me ke kākau inoa ʻana.

HOOLAHA HANA

cpf5
cpf6

Kolea Countec Bottled Packaging Line

cpf7
cpf8

ʻO Taiwan CVC Bottled Packaging Line

cpf9
cpf10

Italia CAM Board Packaging Line

cpf11

Mekini Fette Compacting German

cpf12

ʻO Iapana Viswill Tablet ʻIke

cpf14-1

Keena Mana o DCS

HOA

Ka launa pū ʻana o ka honua
Ka launa pū ʻana o ka honua
ʻO ka launa pū ʻana o ka home
ʻO ka launa pū ʻana o ka home

  • Mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou